Hans Gelderblom, MD, PhD

Leiden University Medical Center
Leiden, Zuid-Holland, Netherlands

Disclosure information not submitted.

Presentation(s):

• Paper 51 - PANDEMIC DRIVEN PREOPERATIVE HYPOFRACTIONATED RADIOTHERAPY FOR SOFT TISSUE SARCOMAS

  Friday, November 15, 2024
  11:15 AM – 12:45 PM PST

• Paper 105 - EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES OF VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE MOTION PHASE 3 TRIAL

  Saturday, November 16, 2024
  3:30 PM – 4:30 PM PST

• Paper 106 - SAFETY, EFFICACY, AND PATIENT-REPORTED OUTCOMES WITH VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR WHO RECEIVED PRIOR ANTI-COLONY-STIMULATING FACTOR 1 THERAPY: ONGOING PHASE 2 STUDY

  Saturday, November 16, 2024
  3:30 PM – 4:30 PM PST